{"id":1243,"date":"2026-11-02T08:58:34","date_gmt":"2026-11-02T06:58:34","guid":{"rendered":"https:\/\/www.pqra.gr\/member-state-supply-requests-under-the-eu-pharma-package-a-new-obligation-to-launch\/"},"modified":"2026-11-02T09:02:00","modified_gmt":"2026-11-02T07:02:00","slug":"member-state-supply-requests-under-the-eu-pharma-package-a-new-obligation-to-launch","status":"publish","type":"post","link":"https:\/\/www.pqra.gr\/el\/member-state-supply-requests-under-the-eu-pharma-package-a-new-obligation-to-launch\/","title":{"rendered":"Member State Supply Requests Under the EU Pharma Package: A New Obligation to Launch"},"content":{"rendered":"<p style=\"font-size:19px;line-height:1.7;color:#33414d;\"><strong>Under the reformed EU pharmaceutical legislation, Member States will be able to ask holders of products with market protection to place them on the national market and supply sufficient quantities. For companies that prioritise some markets over others, this is a significant change.<\/strong><\/p>\n<h2>What the analyses say<\/h2>\n<p>Published summaries of the final texts state that where a medicine enjoys market protection, a Member State may require the holder to supply enough quantity to meet patient needs in that country. Safeguards are intended to prevent the mechanism from facilitating parallel trade to other Member States. Reported timing places the mechanism roughly one year after entry into force, and consequences of non-compliance may include loss of protection or financial penalties.<\/p>\n<h2>Why it matters for launch sequencing<\/h2>\n<ul><li><strong>Smaller markets gain leverage.<\/strong> Countries such as Greece, where launches have sometimes been delayed, can formally request supply.<\/li><li><strong>Authorisation timelines overlap.<\/strong> Because a centralised procedure can take over a year, applications submitted from early 2027 may already be affected.<\/li><li><strong>Pricing and supply are linked.<\/strong> A request to launch cannot be separated from the price and reimbursement negotiation that makes launch viable.<\/li><\/ul>\n<h2>Preparing a response<\/h2>\n<p>Companies should maintain a market-by-market launch intent, with documented commercial rationale and supply capacity. A prepared dossier on pricing discussions, reimbursement status and stock availability will be far more useful than an improvised answer to a ministry letter.<\/p>\n<h2>Open questions<\/h2>\n<p>Implementing detail, definitions of sufficient quantity and the interplay with national pricing rules remain to be clarified by secondary legislation and guidance.<\/p>\n<h2>How PQRA helps<\/h2>\n<p>PQRA helps companies build launch sequencing frameworks, prepare Greek pricing and reimbursement submissions, and coordinate with supply chain and regulatory teams for national supply obligations.<\/p>\n<p><strong><a href=\"\/el\/contact\/\">Contact PQRA to discuss your situation<\/a><\/strong><\/p>","protected":false},"excerpt":{"rendered":"<p>Under the reformed EU pharmaceutical legislation, Member States will be able to ask holders of products with market protection to place them on the national market and supply sufficient quantities. For companies that prioritise some markets over others, this is a significant change. What the analyses say Published summaries of the final texts state that [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1275,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"saved_in_kubio":false,"_swpsp_post_exclude":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1243","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Member State Supply Requests Under the EU Pharma Package: A New Obligation to Launch - PQRA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pqra.gr\/el\/member-state-supply-requests-under-the-eu-pharma-package-a-new-obligation-to-launch\/\" \/>\n<meta property=\"og:locale\" content=\"el_GR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Member State Supply Requests Under the EU Pharma Package: A New Obligation to Launch - PQRA\" \/>\n<meta property=\"og:description\" content=\"Under the reformed EU pharmaceutical legislation, Member States will be able to ask holders of products with market protection to place them on the national market and supply sufficient quantities. For companies that prioritise some markets over others, this is a significant change. What the analyses say Published summaries of the final texts state that [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pqra.gr\/el\/member-state-supply-requests-under-the-eu-pharma-package-a-new-obligation-to-launch\/\" \/>\n<meta property=\"og:site_name\" content=\"PQRA\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-02T06:58:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-02T07:02:00+00:00\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u03a3\u03c5\u03bd\u03c4\u03ac\u03c7\u03b8\u03b7\u03ba\u03b5 \u03b1\u03c0\u03cc\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u0395\u03ba\u03c4\u03b9\u03bc\u03ce\u03bc\u03b5\u03bd\u03bf\u03c2 \u03c7\u03c1\u03cc\u03bd\u03bf\u03c2 \u03b1\u03bd\u03ac\u03b3\u03bd\u03c9\u03c3\u03b7\u03c2\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 \u03bb\u03b5\u03c0\u03c4\u03cc\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/member-state-supply-requests-under-the-eu-pharma-package-a-new-obligation-to-launch\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/member-state-supply-requests-under-the-eu-pharma-package-a-new-obligation-to-launch\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#\\\/schema\\\/person\\\/31e1a03125e7281efaddd7278681af2c\"},\"headline\":\"Member State Supply Requests Under the EU Pharma Package: A New Obligation to Launch\",\"datePublished\":\"2026-11-02T06:58:34+00:00\",\"dateModified\":\"2026-11-02T07:02:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/member-state-supply-requests-under-the-eu-pharma-package-a-new-obligation-to-launch\\\/\"},\"wordCount\":297,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/member-state-supply-requests-under-the-eu-pharma-package-a-new-obligation-to-launch\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pqra.gr\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/pqra-cover-13.png\",\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"el\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.pqra.gr\\\/member-state-supply-requests-under-the-eu-pharma-package-a-new-obligation-to-launch\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/member-state-supply-requests-under-the-eu-pharma-package-a-new-obligation-to-launch\\\/\",\"url\":\"https:\\\/\\\/www.pqra.gr\\\/member-state-supply-requests-under-the-eu-pharma-package-a-new-obligation-to-launch\\\/\",\"name\":\"Member State Supply Requests Under the EU Pharma Package: A New Obligation to Launch - PQRA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/member-state-supply-requests-under-the-eu-pharma-package-a-new-obligation-to-launch\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/member-state-supply-requests-under-the-eu-pharma-package-a-new-obligation-to-launch\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pqra.gr\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/pqra-cover-13.png\",\"datePublished\":\"2026-11-02T06:58:34+00:00\",\"dateModified\":\"2026-11-02T07:02:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/member-state-supply-requests-under-the-eu-pharma-package-a-new-obligation-to-launch\\\/#breadcrumb\"},\"inLanguage\":\"el\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pqra.gr\\\/member-state-supply-requests-under-the-eu-pharma-package-a-new-obligation-to-launch\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"el\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/member-state-supply-requests-under-the-eu-pharma-package-a-new-obligation-to-launch\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.pqra.gr\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/pqra-cover-13.png\",\"contentUrl\":\"https:\\\/\\\/www.pqra.gr\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/pqra-cover-13.png\",\"width\":1200,\"height\":630},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/member-state-supply-requests-under-the-eu-pharma-package-a-new-obligation-to-launch\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.pqra.gr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Member State Supply Requests Under the EU Pharma Package: A New Obligation to Launch\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#website\",\"url\":\"https:\\\/\\\/www.pqra.gr\\\/\",\"name\":\"PQRA\",\"description\":\"Your trusted partner in Pharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pqra.gr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"el\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#organization\",\"name\":\"PQRA\",\"url\":\"https:\\\/\\\/www.pqra.gr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"el\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.pqra.gr\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/pqra-logo-white.png\",\"contentUrl\":\"https:\\\/\\\/www.pqra.gr\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/pqra-logo-white.png\",\"width\":594,\"height\":362,\"caption\":\"PQRA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#\\\/schema\\\/person\\\/31e1a03125e7281efaddd7278681af2c\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"el\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/656b750ec6bc02db9de84dc3080e82be722c7777ef23ff04d6e8e7a0ac541a45?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/656b750ec6bc02db9de84dc3080e82be722c7777ef23ff04d6e8e7a0ac541a45?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/656b750ec6bc02db9de84dc3080e82be722c7777ef23ff04d6e8e7a0ac541a45?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\\\/\\\/www.pqra.gr\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Member State Supply Requests Under the EU Pharma Package: A New Obligation to Launch - PQRA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pqra.gr\/el\/member-state-supply-requests-under-the-eu-pharma-package-a-new-obligation-to-launch\/","og_locale":"el_GR","og_type":"article","og_title":"Member State Supply Requests Under the EU Pharma Package: A New Obligation to Launch - PQRA","og_description":"Under the reformed EU pharmaceutical legislation, Member States will be able to ask holders of products with market protection to place them on the national market and supply sufficient quantities. For companies that prioritise some markets over others, this is a significant change. What the analyses say Published summaries of the final texts state that [&hellip;]","og_url":"https:\/\/www.pqra.gr\/el\/member-state-supply-requests-under-the-eu-pharma-package-a-new-obligation-to-launch\/","og_site_name":"PQRA","article_published_time":"2026-11-02T06:58:34+00:00","article_modified_time":"2026-11-02T07:02:00+00:00","author":"admin","twitter_card":"summary_large_image","twitter_misc":{"\u03a3\u03c5\u03bd\u03c4\u03ac\u03c7\u03b8\u03b7\u03ba\u03b5 \u03b1\u03c0\u03cc":"admin","\u0395\u03ba\u03c4\u03b9\u03bc\u03ce\u03bc\u03b5\u03bd\u03bf\u03c2 \u03c7\u03c1\u03cc\u03bd\u03bf\u03c2 \u03b1\u03bd\u03ac\u03b3\u03bd\u03c9\u03c3\u03b7\u03c2":"1 \u03bb\u03b5\u03c0\u03c4\u03cc"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pqra.gr\/member-state-supply-requests-under-the-eu-pharma-package-a-new-obligation-to-launch\/#article","isPartOf":{"@id":"https:\/\/www.pqra.gr\/member-state-supply-requests-under-the-eu-pharma-package-a-new-obligation-to-launch\/"},"author":{"name":"admin","@id":"https:\/\/www.pqra.gr\/#\/schema\/person\/31e1a03125e7281efaddd7278681af2c"},"headline":"Member State Supply Requests Under the EU Pharma Package: A New Obligation to Launch","datePublished":"2026-11-02T06:58:34+00:00","dateModified":"2026-11-02T07:02:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pqra.gr\/member-state-supply-requests-under-the-eu-pharma-package-a-new-obligation-to-launch\/"},"wordCount":297,"commentCount":0,"publisher":{"@id":"https:\/\/www.pqra.gr\/#organization"},"image":{"@id":"https:\/\/www.pqra.gr\/member-state-supply-requests-under-the-eu-pharma-package-a-new-obligation-to-launch\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pqra.gr\/wp-content\/uploads\/2026\/11\/pqra-cover-13.png","articleSection":["Uncategorized"],"inLanguage":"el","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.pqra.gr\/member-state-supply-requests-under-the-eu-pharma-package-a-new-obligation-to-launch\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.pqra.gr\/member-state-supply-requests-under-the-eu-pharma-package-a-new-obligation-to-launch\/","url":"https:\/\/www.pqra.gr\/member-state-supply-requests-under-the-eu-pharma-package-a-new-obligation-to-launch\/","name":"Member State Supply Requests Under the EU Pharma Package: A New Obligation to Launch - PQRA","isPartOf":{"@id":"https:\/\/www.pqra.gr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pqra.gr\/member-state-supply-requests-under-the-eu-pharma-package-a-new-obligation-to-launch\/#primaryimage"},"image":{"@id":"https:\/\/www.pqra.gr\/member-state-supply-requests-under-the-eu-pharma-package-a-new-obligation-to-launch\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pqra.gr\/wp-content\/uploads\/2026\/11\/pqra-cover-13.png","datePublished":"2026-11-02T06:58:34+00:00","dateModified":"2026-11-02T07:02:00+00:00","breadcrumb":{"@id":"https:\/\/www.pqra.gr\/member-state-supply-requests-under-the-eu-pharma-package-a-new-obligation-to-launch\/#breadcrumb"},"inLanguage":"el","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pqra.gr\/member-state-supply-requests-under-the-eu-pharma-package-a-new-obligation-to-launch\/"]}]},{"@type":"ImageObject","inLanguage":"el","@id":"https:\/\/www.pqra.gr\/member-state-supply-requests-under-the-eu-pharma-package-a-new-obligation-to-launch\/#primaryimage","url":"https:\/\/www.pqra.gr\/wp-content\/uploads\/2026\/11\/pqra-cover-13.png","contentUrl":"https:\/\/www.pqra.gr\/wp-content\/uploads\/2026\/11\/pqra-cover-13.png","width":1200,"height":630},{"@type":"BreadcrumbList","@id":"https:\/\/www.pqra.gr\/member-state-supply-requests-under-the-eu-pharma-package-a-new-obligation-to-launch\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pqra.gr\/"},{"@type":"ListItem","position":2,"name":"Member State Supply Requests Under the EU Pharma Package: A New Obligation to Launch"}]},{"@type":"WebSite","@id":"https:\/\/www.pqra.gr\/#website","url":"https:\/\/www.pqra.gr\/","name":"PQRA","description":"Your trusted partner in Pharma","publisher":{"@id":"https:\/\/www.pqra.gr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pqra.gr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"el"},{"@type":"Organization","@id":"https:\/\/www.pqra.gr\/#organization","name":"PQRA","url":"https:\/\/www.pqra.gr\/","logo":{"@type":"ImageObject","inLanguage":"el","@id":"https:\/\/www.pqra.gr\/#\/schema\/logo\/image\/","url":"https:\/\/www.pqra.gr\/wp-content\/uploads\/2026\/07\/pqra-logo-white.png","contentUrl":"https:\/\/www.pqra.gr\/wp-content\/uploads\/2026\/07\/pqra-logo-white.png","width":594,"height":362,"caption":"PQRA"},"image":{"@id":"https:\/\/www.pqra.gr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.pqra.gr\/#\/schema\/person\/31e1a03125e7281efaddd7278681af2c","name":"admin","image":{"@type":"ImageObject","inLanguage":"el","@id":"https:\/\/secure.gravatar.com\/avatar\/656b750ec6bc02db9de84dc3080e82be722c7777ef23ff04d6e8e7a0ac541a45?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/656b750ec6bc02db9de84dc3080e82be722c7777ef23ff04d6e8e7a0ac541a45?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/656b750ec6bc02db9de84dc3080e82be722c7777ef23ff04d6e8e7a0ac541a45?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/www.pqra.gr"]}]}},"_links":{"self":[{"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/posts\/1243","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/comments?post=1243"}],"version-history":[{"count":1,"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/posts\/1243\/revisions"}],"predecessor-version":[{"id":1276,"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/posts\/1243\/revisions\/1276"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/media\/1275"}],"wp:attachment":[{"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/media?parent=1243"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/categories?post=1243"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/tags?post=1243"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}